Related Experiment Video
Updated: May 23, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
[Should we screen and treat subclinical hypothyroidism?]
Vanessa Virgini1, Tinh-Hai Collet, Emanuel Christ
1Clinique universitaire et Policlinique de médecine interne générale, Hôpital de l'Ile, Université de Berne. vanessa.virgini@insel.ch
Revue Medicale Suisse
|April 5, 2012
Summary
Subclinical hypothyroidism (elevated thyroid stimulating hormone, normal thyroxine) is common in older adults and may cause health issues. A new trial will clarify treatment benefits for elderly health.
Area of Science:
- Endocrinology
- Geriatrics
- Internal Medicine
Context:
- Subclinical hypothyroidism is common in individuals over 65.
- It is characterized by elevated thyroid stimulating hormone (TSH) and normal thyroxine (T4) levels.
- Potential health consequences include cardiovascular diseases and cognitive impairment.
Purpose:
- To review current data on the risks and benefits of thyroxine replacement therapy for subclinical hypothyroidism.
- To present findings from a large European randomized clinical trial on this topic.
- To provide evidence for improved clinical care and health maintenance in the elderly.
Summary:
- This review examines the association between subclinical hypothyroidism and adverse health outcomes in the elderly.
- It evaluates the potential benefits of thyroxine replacement therapy.
- A major European randomized clinical trial is discussed to resolve treatment controversies.
Impact:
- The findings aim to clarify the clinical management of subclinical hypothyroidism in older adults.
- This research will provide reliable data to support evidence-based healthcare decisions.
- Improved understanding can lead to better health outcomes for the aging population.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...